Acinetobacter: A War Zone in the Hospital

References (55)

1. 1 Acinetobacter baumannii : Emergence of a Successful Pathogen [DOI]
2. 2 The Epidemiology and Control of Acinetobacter baumannii in Health Care Facilities [DOI]
3. 3 Acinetobacter baumannii : evolution of a global pathogen [DOI]
4. 4 Emerging broad-spectrum resistance in Pseudomonas aeruginosa and Acinetobacter baumannii : Mechanisms and epidemiology [DOI]
5. 5 Acinetobacter baumannii : human infections, factors contributing to pathogenesis and animal models [DOI]
6. 6 Global evolution of multidrug-resistant Acinetobacter baumannii clonal lineages [DOI]
7. 7 Acinetobacter: an old friend, but a new enemy [DOI]
8. 8 An Outbreak of Multidrug-Resistant Acinetobacter baumannii-calcoaceticus Complex Infection in the US Military Health Care System Associated with Military Operations in Iraq [DOI]
9. 9 Antimicrobial resistance in Acinetobacter baumannii : From bench to bedside [DOI]
10. 10 Global dissemination of extensively drug‐resistant carbapenemase‐producing E nterobacteriaceae: clinical perspectives on detection, treatment and infection control [DOI]
11. 11 Acinetobacter baumannii: Evolution of Antimicrobial Resistance—Treatment Options [DOI]
12. 12 Resources for Genetic and Genomic Analysis of Emerging Pathogen Acinetobacter baumannii [DOI]
13. 13 Acinetobacter species as model microorganisms in environmental microbiology: current state and perspectives [DOI]
14. 14 Multidrug-ResistantAcinetobacterExtremity Infections in Soldiers [DOI]
15. 15 Biofilm formation by Acinetobacter baumannii.
16. 16 Cephalosporinase over-expression resulting from insertion of ISAba1 in Acinetobacter baumannii [DOI]
17. 17 The Role of Nanotechnology in Combating Multi-Drug Resistant Bacteria [DOI]
18. 18 Treatment Options for Carbapenem-Resistant and Extensively Drug-Resistant Acinetobacter baumannii Infections [DOI]
19. 19 Seasonal and Temperature-Associated Increases in Gram-Negative Bacterial Bloodstream Infections among Hospitalized Patients [DOI]
20. 20 Bacteriophages as an Alternative Strategy for Fighting Biofilm Development [DOI]
21. 21 Contemporary resistance trends and mechanisms for the old antibiotics colistin, temocillin, fosfomycin, mecillinam and nitrofurantoin [DOI]
22. 22 β-Lactam/β-Lactamase Inhibitor Combinations [DOI]
23. 23 Combination antibiotic treatment versus monotherapy for multidrug-resistant, extensively drug-resistant, and pandrug-resistant Acinetobacter infections: a systematic review [DOI]
24. 24 Effectiveness and safety of high-dose tigecycline-containing regimens for the treatment of severe bacterial infections [DOI]
25. 25 Ribotyping of the Acinetobacter calcoaceticus-Acinetobacter baumannii complex [DOI]
26. 26 Naturally Transformable Acinetobacter sp. Strain ADP1 Belongs to the Newly Described Species Acinetobacter baylyi [DOI]
27. 27 Identification of a New Allelic Variant of theAcinetobacter baumanniiCephalosporinase, ADC-7 β-Lactamase: Defining a Unique Family of Class C Enzymes [DOI]
28. 28 Outbreak of Carbapenem-Resistant Acinetobacter baumannii Producing the Carbapenemase OXA-23 in a Tertiary Care Hospital of Papeete, French Polynesia [DOI]
29. 29 IMP-4 and OXA β-lactamases in Acinetobacter baumannii from Singapore [DOI]
30. 30 Activity of Cecropin A-Melittin Hybrid Peptides against Colistin-Resistant Clinical Strains of Acinetobacter baumannii : Molecular Basis for the Differential Mechanisms of Action [DOI]
31. 31 Global Comparison of the Membrane Subproteomes between a Multidrug-Resistant Acinetobacter baumannii Strain and a Reference Strain [DOI]
32. 32 Update on the Epidemiology, Treatment, and Outcomes of Carbapenem-resistant Acinetobacter infections [DOI]
33. 33 Sulbactam efficacy in experimental models caused by susceptible and intermediate Acinetobacter baumannii strains [DOI]
34. 34 Tetracyclines for multidrug-resistant Acinetobacter baumannii infections [DOI]
35. 35 Antibiotic regimens for treatment of infections due to multidrug-resistant Gram-negative pathogens: An evidence-based literature review [DOI]
36. 36 First Steps Towards a Vaccine against Acinetobacter baumannii [DOI]
37. 37 Novel therapies for treatment of multi-drug resistantAcinetobacter baumanniiskin infections [DOI]
38. 38 Efficacy and Safety of Polymyxins for the Treatment of Acinectobacter baumannii Infection: A Systematic Review and Meta-Analysis [DOI]
39. 39 Prevalence of ISAba1in epidemiologically unrelatedAcinetobacter baumanniiclinical isolates [DOI]
40. 40 Quantitative proteomics to study carbapenem resistance in Acinetobacter baumannii [DOI]
41. 41 High prevalence of blaOXA-23 in Acinetobacter spp. and detection of blaNDM-1 in A. soli in Cuba: report from National Surveillance Program (2010–2012) [DOI]
42. 42 Genes Involved in the Biosynthesis and Transport of Acinetobactin inAcinetobacter baumannii [DOI]
43. 43 Investigation of antibiotic resistance in the genomic era of multidrug-resistant Gram-negative bacilli, especially Enterobacteriaceae , Pseudomonas and Acinetobacter [DOI]
44. 44 A Novel Antibacterial Gene Transfer Treatment for Multidrug-Resistant Acinetobacter Baumannii-Induced Burn Sepsis [DOI]
45. 45 Current Molecular Methods in Epidemiological Typing of Acinetobacter Baumannii [DOI]
46. 46 Genotyping methods for monitoring the epidemic evolution of A. baumannii strains [DOI]
47. 47 Inter-country transfer of Gram-negative organisms carrying the VIM-4 and OXA-58 carbapenem-hydrolysing enzymes [DOI]
48. 48 Systemic review/Meta-analysis Clinical efficacy and safety of colistin treatment in patients with pulmonary infection caused by Pseudomonas aeruginosa or Acinetobacter baumannii : a meta-analysis [DOI]
49. 49 Casualties of war: the infection control assessment of civilians transferred from conflict zones to specialist units overseas for treatment [DOI]
50. 50 Electron-microscopic observation of adherence of Acinetobacter baumannii to red blood cells.
51. 51 Infections in patients undergoing craniotomy: risk factors associated with post-craniotomy meningitis [DOI]
52. 52 Fulminant Community-Acquired Acinetobacter baumannii Pneumonia as a Distinct Clinical Syndrome [DOI]
53. 53 Bacteria Recovered from Patients Admitted to a Deployed U.S. Military Hospital in Baghdad, Iraq [DOI]
54. 54 [Studies on bacterial taxonomy. X. The revision of species under Acromobacter group].
55. 55 Dissemination of imipenem-resistant Acinetobacter baumannii strains carrying the ISAba1–bla OXA-23 genes in a Chinese hospital [DOI]

Cited by 2

Showing 1 of 2 known citations — external sources report more than can currently be individually listed.

Related research

• Covid-2019:“A Microbiological Monster” — shares topic coverage
• Molecular Characterization and Antibiogram of Staphylococcus and Pseudomonas Species Isolated from Patients Attending Rivers State Teaching Hospital, Nigeria — shares topic coverage
• Blood Stream Infections in Children with Malignancies: A Single Center Experience Risk Factors, Microbiological Isolates and Sensitivity Pattern — shares topic coverage
• Microbiological and Physico-chemical Analyses of Borehole Water Samples from Private Schools in Umuahia Metropolis, Abia State, Nigeria — shares topic coverage
• Molecular Biology Methods to Assess Microbiological Hazard Concerning Objects of Cultural Heritage — shares topic coverage